tirzepatide blood in stool Tirzepatide-Associated Colonic Ischemia GLP‑1 and diarrhea: why it
Description
he previously co-founded the real estate marketplace Trulia and steered it through a successful IPO in 2012 before its eventual $3.5 billion merger with Zillow

Weight-Loss Drug Tirzepatide Reduces Heart Failure Deaths Weight-loss and diabetes drug tirzepatide can reduce the risk of death or worsening heart failure for patients with heart failure, preserved heart pump function and obesity, new research from UVA Health reveals

For Ozempic, the maximum FDA-approved dose for blood sugar control is 2.0 mg per week

individual results vary significantly Both medications require adherence to dosing schedule and lifestyle modifications Higher doses generally produce better results but may have more side effects Not everyone reaches maximum doses due to side effect tolerance Actual weight loss depends on starting weight, diet, exercise, and individual metabolism Time to See Results: Semaglutide: Weeks 1-4: Minimal weight loss (adjusting to medication) Weeks 4-12: Noticeable appetite reduction and initial weight loss (5-8 pounds) Weeks 12-24: Steady weight loss (1-2 pounds per week) Weeks 24-68: Continued weight loss at slower pace Tirzepatide: Weeks 1-4: Minimal weight loss (adjusting to medication) Weeks 4-12: Noticeable appetite reduction and initial weight loss (8-12 pounds) Weeks 12-24: Steady weight loss (1.5-2.5 pounds per week) Weeks 24-72: Continued weight loss, often at sustained pace Both medications show continued weight loss throughout the clinical trial periods, with weight loss plateauing around month 16-20 for most participants

Increase in number of cases of acute and chronic pancreatitis linked to GLP-1 medicines owenhaskins Jun 26, 2025 2 min read Data from the UKs medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), has revealed that since glucagon-like peptide-1 receptor agonists (GLP-1) were licensed there have been hundreds of cases of acute and chronic pancreatitis among people taking GLP-1 medicines